12th Sep 2005 06:00
Pfizer Expects Acquisition of Vicuron Pharmaceuticals to Close on September 14, 2005 Hart.Scott.Rodino Waiting Period Expires NEW YORK, Sept. 12 -- Pfizer Inc (NYSE: PFE) said today that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 relating to its acquisition of Vicuron Pharmaceuticals (Nasdaq: MICU; Nuovo Mercato) has expired and that the company expects the transaction will close on Sept. 14. The closing is subject to completion of customary conditions to closing. DISCLOSURE NOTICE: The information contained in this release is as of September 11, 2005. The Company assumes no obligation to update any forward-looking statements contained in this release as a result of new information or future events or developments. This release contains forward-looking information about the acquisition of Vicuron. This forward-looking information is subject to substantial risks and uncertainties that could delay or prevent the completion of the acquisition, including the satisfaction of the closing conditions set forth in the merger agreement. Reference also is made to the description of risks and uncertainties in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2004 and in its reports on Forms 10-Q and 8-K. SOURCE Pfizer Inc 09/12/2005 /CONTACT: Paul Fitzhenry of Pfizer Inc, +1-212-733-4637/ /Company News On-Call: Pfizer's press releases are available through PR Newswire's Company News On-Call service on PRN's Web Site. Visit http://www.prnewswire.com/comp/688250.html/ /Photo: A free corporate logo to accompany this story is available immediately via Wieck Photo Database to any media with telephoto receiver or electronic darkroom, PC or Macintosh, that can accept overhead transmissions. To retrieve a logo, please call 972-392-0888./ /Company News On-Call: http://www.prnewswire.com/comp/688250.html / /Web site: http://www.pfizer.com / (PFE) ENDPFIZER INCRelated Shares:
PFZ.L